PARIS – Biogroup, the leading private medical laboratory services group in France and Belgium, has successfully completed through its two main subsidiaries the issuance of EUR800million in aggregate principal amount of senior secured notes due 2028 with a fixed interest rate of 3.375% and the issuance of EUR250m in aggregate principal amount of senior secured notes due 2029 with a fixed interest rate of 5%.
In parallel to these issuances, Biogroup has entered into a new senior facilities agreement in an aggregate principal amount of EUR1.721billion
Raising nearly EUR2.771b has enabled Biogroup to refinance its existing debt and optimize its financing structure.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
